Codagenix announces promising findings for intranasal COVID vaccine (By: Lisa Schnirring)
Against the backdrop of a global push for new COVID vaccines that can provide broader and longer lasting protection, Codagenix today announced that its live-attenuated intranasal vaccine candidate prompted robust humoral and cellular immunity in adults…









